Fundamental Compounding

FUNDAMENTAL COMPOUNDING is an accredited 3-day, 21-hour (2.1 CEUs) practice-based course designed for pharmacists, technicians, marketers, and students who are new to compounding or who have had training in the past, but want a refresher. Physicians and other health care professionals are welcome to attend. This hands-on course focuses on the proper preparation of fundamental dosage forms utilized by pharmacies that are compounding medications for their patients. Participants will learn...
American College of Apothecaries

Fundamental Compounding

FUNDAMENTAL COMPOUNDING is an accredited 3-day, 21-hour (2.1 CEUs) practice-based course designed for pharmacists, technicians, marketers, and students who are new to compounding or who have had training in the past, but want a refresher. Physicians and other health care professionals are welcome to attend. This hands-on course focuses on the proper preparation of fundamental dosage forms utilized by pharmacies that are compounding medications for their patients. Participants will learn...
American College of Apothecaries

Fundamental Compounding

FUNDAMENTAL COMPOUNDING is an accredited 3-day, 21-hour (2.1 CEUs) practice-based course designed for pharmacists, technicians, marketers, and students who are new to compounding or who have had training in the past, but want a refresher. Physicians and other health care professionals are welcome to attend. This hands-on course focuses on the proper preparation of fundamental dosage forms utilized by pharmacies that are compounding medications for their patients. Participants will learn...
American College of Apothecaries

Biologics for Severe Asthma: Case-Based Conversations

This CME-accredited four-part CME Snapshot™ series is intended for pulmonologists, allergists, and other specialists involved in the long-term care of patients with severe asthma. In this educational series, expert faculty will review clinical practice guidelines, discuss new approaches to therapy, and hear directly from patients with severe asthma.
Integritas Communications

BLOCK HIV/HCV

Approximately 25% of all individuals infected with HIV are coinfected with HCV.1 Of critical significance, HIV increases the rate of progression of HCV-related hepatic fibrosis, and HCV is associated with a 3-fold increase in HIV antiretroviral therapy-induced liver toxicity.2 Further, these synergistic diseases often occur in adverse socioeconomic conditions that significantly increase the vulnerability and decrease the overall health status of at-risk populations.3 Whereas HIV infection is n...
Integritas Communications

Looking at the Big Picture of IBD

The burden of inflammatory bowel diseases (IBD), of which Chroh's disease and ulcerative colitis are the primary entities, is significant and wide ranging. IBD that is not well-controlled impairs quality of life, social activities, travel and ability to work, leading to higher rates of absenteeism and permanent work disability.1,2 The idiopathic intestinal inflammation of IBD requires life-long treatment and accounts for enormous hospitalization costs. According to data from the U.S. Nationa...
Integritas Communications

JAK Inhibition in Rheumatoid Arthritis

With increasing evidence showing that the Janus kinase (JAK) inhibition can be used as a target for certain immune-mediated diseases, this activity reviews the benefits and safety concerns gastroenterologists and rheumatologists need to consider.
Integritas Communications

JAK Inhibition in Inflammatory Bowel Disease

This activity has been designed to meet the educational needs of gastroenterologists and rheumatologists who care for patients with inflammatory bowel disease or rheumatoid arthritis.
Integritas Communications

JAK-STAT Signaling and Disease Pathogenesis in RA and IBD

With increasing evidence showing that the Janus kinase (JAK) inhibition can be used as a target for certain immune-mediated diseases, this activity reviews the benefits and safety concerns gastroenterologists and rheumatologists need to consider.
Integritas Communications

Raising the Bar by Lowering the Target

This CME-accredited CME Snapshot™ highlights program compiles the key takeaways from a seven-part series intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During this activity, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience with identifying and managin...
Integritas Communications

Pharmacoeconomic Outcomes of Suboptimal LDL-C Management

This accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein cholestero...
Integritas Communications

Tailored Lipid-Lowering Regiments for Specific Very High-Risk Profiles

This accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein cholestero...
Integritas Communications

TKI Therapy in CML: Emerging Treatments, Ensuring Safety

This Virtual Practice summarizes advances in tyrosine kinase inhibitor (TKI) treatment of chronic myeloid leukemia (CML) in the context of disease- and patient-specific characteristics; reviews the most effective methods for monitoring early response and long-term therapeutic outcomes; assesses the milestones and mutational analyses to identify when a change in TKI therapy is needed; compares toxicity profiles of the currently available TKI agents; and examines how toxicity could interact with...
Albert Einstein College of Medicine and RedMedEd

Managing Chronic Pain

Chronic pain management is a global health priority. Millions of adults (11%-19% of the US population) suffer daily from chronic, noncancer pain. A conservative estimate of the economic burden of pain in the US, including both healthcare costs and lost work productivity, is $560 - $635 billion annually. Most patients use a combination of non-drug approaches and medication to help alleviate pain. Although all drug treatments have risks that must be carefully weighed against the potential benefi...
The Rx Consultant

Collaborating with Patients to Reduce Long-Term Hypercholesterolemia Risks

This CME-accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein choles...
Integritas Communications

Tailored Lipid-Lowering Regiments for Specific Very High-Risk Profiles

This CME-accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein choles...
Integritas Communications

Pharmacoeconomic Outcomes of Suboptimal LDL-C Management

This CME-accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein choles...
Integritas Communications

Clinical Issues in Rheumatoid Arthritis: Discussions and Debates on the Evolving Roles of Targeted Synthetic DMARDs

Rheumatoid arthritis (RA) is a chronic inflammatory joint disease that can cause bone and cartilage damage and lead to disability.1 RA affects about 24.5 million people, with 5 and 50 per 100,000 people newly developing the condition each year.1,2 RA has resulted in increased mortality in recent years, creating a need for an understanding of treat-to-target recommendations and appropriate disease activity measures.3 Adopting treat-to-target strategies in RA patients has shown great promise in ...
Integritas Communications

Update on Indications, Interactions and Complications in the Use of Pharmaceuticals Alaska Cruise

1. Drug Abuse and Misuse 2. Understanding Patient’s Approaches in Self-Care 3. Optimizing Medication Adherence and Outcomes 4. From Pharmacogenomics to Personalized Medicine 5. Comprehensive Medication Management Services 6. Pharmaceutical Regulatory Update, Key Product Approvals, Guideline Updates
Continuing Education, Inc

Clinical Profiles of Current and Emerging GLP-1 RAs (Module 1 of 4)

This CME-accredited CME Snapshot™ four-part series is intended for endocrinologists, primary care providers (PCPs), and other health care providers involved in the identification, evaluation, and treatment of patients with T2DM. During these activities, two expert faculty will participate in a series of interactive discussions on recent evidence related to glucagon-like peptide 1 receptor agonists (GLP-1 RAs). The faculty will also review freely available patient- and caregiver directed educ...
Integritas Communications

Through Your Patient’s Eyes™ - Comprehensive Relief from Cancer Pain: Expanding the Conversation on Opioid-Induced Constipation

Despite a growing number of specific treatment options, many patients with cancer pain still suffer from opioid-induced constipation (OIC).1-3 Open communication among patients, caregivers, and treating clinicians is essential to determine the severity and psychosocial consequences of OIC.1-4 Patients with cancer pain and their proxies, however, are often reluctant to discuss opioid-related gastrointestinal symptoms and effects on quality of life. To address this barrier, clinicians should pro...
Integritas Communications

Tailoring Long-Term Maintenance Regimens for Severe Asthma

This CME-accredited four-part CME Snapshot™ series is intended for pulmonologists, allergists, and other specialists involved in the long-term care of patients with severe asthma. In this educational series, expert faculty will review clinical practice guidelines, discuss new approaches to therapy, and hear directly from patients with severe asthma.
Integritas Communications

Guidelines on Severe Asthma: A Practical Synthesis for Specialists

This CME-accredited four-part CME Snapshot™ series is intended for pulmonologists, allergists, and other specialists involved in the long-term care of patients with severe asthma. In this educational series, expert faculty will review clinical practice guidelines, discuss new approaches to therapy, and hear directly from patients with severe asthma.
Integritas Communications

The Nexus of NASH and T2DM: The Emerging Role of the Diabetologist

NAFLD is a spectrum of potentially progressive liver disorders, ranging from simple hepatic steatosis to such severe forms as NASH, fibrosis, and cirrhosis.1 The prevalence rates of both NAFLD and NASH have been steadily trending upwards for years, mirroring the rapid and well-documented expansions of patient populations with obesity and/or T2DM.2-4 Thus, in the coming decade, burdens associated with this under-recognized epidemic are likely to increase exponentially for patients, clinicians, ...
Integritas Communications

Inhibition of IL-6 Signaling in the Management of Rheumatoid Arthritis

This CME/CE-accredited CME Snapshot™ series of educational videos has been created for rheumatologists and other clinicians involved in treating patients with rheumatoid arthritis (RA). During each 15-minute activity, two expert rheumatologists focus on a specific aspect of long-term RA management, including practical advice on implementing international treat-to-target guidelines as well as the mechanistic profiles and clinical evidence for therapies designed to inhibit signaling via interl...
Integritas Communications

JAK Inhibitors in the Management of Rheumatoid Arthritis

This CME/CE-accredited CME Snapshot™ series of educational videos has been created for rheumatologists and other clinicians involved in treating patients with rheumatoid arthritis (RA). During each 15-minute activity, two expert rheumatologists focus on a specific aspect of long-term RA management, including practical advice on implementing international treat-to-target guidelines as well as the mechanistic profiles and clinical evidence for therapies designed to inhibit signaling via interl...
Integritas Communications

Long-term Cardiovascular Outcomes Trials With PCKS9 Inhibitors

This CME-accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein choles...
Integritas Communications

Novel Nonstatin LDL-C Targets in High-Risk Patients

This CME-accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein choles...
Integritas Communications

Individualizing LDL-C Targets in High-Risk Patients

This CME-accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein choles...
Integritas Communications

Differential Diagnosis Multidisciplinary Management, and Patient Engagement (Module 4)

This CME-accredited CME Snapshot™ four-part series is intended for primary care providers, including internists, family physicians, nurse practitioners, and physician assistants involved in the ongoing management of patients with severe asthma. The faculty will review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making and multidisciplinary care.
Integritas Communications

Patient Engagement Via Open Communication (Module 3)

This CME-accredited CME Snapshot™ four-part series is intended for primary care providers, including internists, family physicians, nurse practitioners, and physician assistants involved in the ongoing management of patients with severe asthma. The faculty will review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making and multidisciplinary care.
Integritas Communications

Identifying Cases of Severe Asthma (Module 2)

This CME-accredited CME Snapshot™ four-part series is intended for primary care providers, including internists, family physicians, nurse practitioners, and physician assistants involved in the ongoing management of patients with severe asthma. The faculty will review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making and multidisciplinary care.
Integritas Communications

Ask the Experts: Identifying the Needs of Patients with Severe Asthma (Module 1)

This CME-accredited CME Snapshot™ four-part series is intended for primary care providers, including internists, family physicians, nurse practitioners, and physician assistants involved in the ongoing management of patients with severe asthma. The faculty will review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making and multidisciplinary care.
Integritas Communications

Long-Term Monitoring Of Patients Treated With Intrathecal Analgesics (Module 4)

This CME-accredited CME/CE Snapshot™ four-part series is intended for pain specialists, pain management nurses, and other clinicians who manage patients treated with intrathecally delivered analgesics for chronic pain. The faculty will also review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making.
Integritas Communications

Initiating Intrathecal Therapy For Patients With Severe Chronic Pain (Module 3)

This CME-accredited CME/CE Snapshot™ four-part series is intended for pain specialists, pain management nurses, and other clinicians who manage patients treated with intrathecally delivered analgesics for chronic pain. The faculty will also review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making.
Integritas Communications

Selecting Patients Who May Benefit From Intrathecal Drug Delivery For Severe Chronic Pain (Module 2)

This CME-accredited CME/CE Snapshot™ four-part series is intended for pain specialists, pain management nurses, and other clinicians who manage patients treated with intrathecally delivered analgesics for chronic pain. The faculty will also review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making.
Integritas Communications

Overview of Intrathecal Therapy For Chronic Pain (Module 1)

This CME-accredited CME/CE Snapshot™ four-part series is intended for pain specialists, pain management nurses, and other clinicians who manage patients treated with intrathecally delivered analgesics for chronic pain. The faculty will also review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making.
Integritas Communications

Practical Recommendations for Noninsulin Injectable Therapies (Module 4 of 4)

This CME-accredited CME Snapshot™ four-part series is intended for endocrinologists, primary care providers (PCPs), and other health care providers involved in the identification, evaluation, and treatment of patients with T2DM. During these activities, two expert faculty will participate in a series of interactive discussions on recent evidence related to glucagon-like peptide 1 receptor agonists (GLP-1 RAs). The faculty will also review freely available patient- and caregiver directed educ...
Integritas Communications

Overcoming Barriers to Injectable Noninsulin Therapies (Module 3 of 4)

This CME-accredited CME Snapshot™ four-part series is intended for endocrinologists, primary care providers (PCPs), and other health care providers involved in the identification, evaluation, and treatment of patients with T2DM. During these activities, two expert faculty will participate in a series of interactive discussions on recent evidence related to glucagon-like peptide 1 receptor agonists (GLP-1 RAs). The faculty will also review freely available patient- and caregiver directed educ...
Integritas Communications

Reducing Cardiovascular Risk in Patients with T2DM (Module 2 of 4)

This CME-accredited CME Snapshot™ four-part series is intended for endocrinologists, primary care providers (PCPs), and other health care providers involved in the identification, evaluation, and treatment of patients with T2DM. During these activities, two expert faculty will participate in a series of interactive discussions on recent evidence related to glucagon-like peptide 1 receptor agonists (GLP-1 RAs). The faculty will also review freely available patient- and caregiver directed educ...
Integritas Communications

Optimizing Immunosuppression, Precision Medicine, and Big Data: The Required Path for Innovation in Transplantation

The optimization of immunosuppression is an important modifiable risk factor that can have a positive impact on long-term outcomes in transplantation. Breakthroughs in transplant procedures and the development of more effective immunosuppressive therapies have improved patient outcomes, with short-term survival rates over 80%. However, by five years post-transplant, up to 25% of patients have returned to dialysis, and 50% of all grafts fail within 10 years. Emerging literature that supports mi...
CME Outfitters

From Pathways to PROs: Translating the Latest Evidence for Current and Emerging JAK Inhibitors to Clinical Practice

Current therapeutic approaches for RA rely on disease-modifying antirheumatic drugs (DMARDs) as well as on biologic therapeutics that target tumor necrosis factor (TNF), interleukin-6 (IL-6), and T cell activation or that eliminate CD20+ B cells. These treatments have limitations, such as waning efficacy over time, side effects, and dosing inconvenience. Clinicians need to be aware of what other treatment options exist or are emerging. Further, rheumatology clinicians often face challenges in ...
CME Outfitters

The PROMIS® of Improved Bone Health in Older Adults

A bone-healthy lifestyle includes a diet that is rich in vitamins and nutrients, regular exercise, and avoidance of smoking and excessive alcohol intake. This, along with essential nutrients calcium and vitamin D, contribute to optimal bone health. Inadequate dietary intake of calcium and vitamin D for long periods of time can cause osteopenia, which can lead to osteoporosis as well as placing individuals at risk for falls and fractures. Fragility fractures due to osteoporosis have far-reachin...
CME Outfitters

The Changing Architecture of HIV Care Review of Novel Agents and Approaches

This CME/CE-accredited CME Snapshot™ four-part series is intended for infectious disease physicians and other clinicians who manage patients with HIV. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with HIV.
Integritas Communications

Clinical Issues in Chronic Pain: Debates and Discussions About Therapeutically Targeting Nerve Growth Factor Signaling

Chronic pain affects 100 million Americans and has significant health and socioeconomic repercussions.1 Appropriate pain management can improve patient quality of life and overall outcomes and also reduce health care costs.1 Although nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids are often prescribed to manage chronic pain, both analgesic classes are associated with risks and are not appropriate for all patients.2-4 The search for additional treatment options with novel mechanisms o...
Integritas Communications

Targeting EGFR Mutation-positive NSCLC: Critical Advances in Care

New developments in the role of mutations in the epidermal growth factor receptor (EGFR) gene are transforming the understanding of how NSCLC progresses as a disease. This insight has enabled NSCLC to evolve from an untreatable disease to one where a number of novel therapeutic options are available, and individualized treatment regimens are now offered to optimize care. This digital flipbook includes pertinent data and video insights into new and practice-changing therapy in the setting of...
ACHL

New Considerations in Diabetes Management

This issue highlights the use of continuous glucose monitoring (CGM) systems, sodiumglucose transport protein-2 (SGLT2) inhibitors, newer insulin formulations, and the expert guideline recommendations focused on individualization of therapy. In 2017, the Centers for Disease Control reported that over 30 million people in the US (~10% of the population) have diabetes, including 7.2 million who are undiagnosed. The total estimated cost of diagnosed diabetes in the US was $327 billion in 201...
The Rx Consultant

Transitioning into a Career in Clinical Research

This course deals with the challenges related to managing change associated with career transition. Understand the clinical research field as well as your career strengths, career interests and values. In addition, focus on your uniqueness and its value to yourself and the market place. Identify transferable skills and accomplishments that can be used in clinical research. Learn from clinical research experts how to market yourself and how to enter the clinical research arena. Pre/co-requis...
Boston College

Partnering with Patients to Navigate the Complexities of Idiopathic Pulmonary Fibrosis

Put your knowledge to the test with the IPF Formative Assessment! Challenge yourself with this self-paced interactive assessment designed to sharpen your knowledge and competency in the diagnosis and management of idiopathic pulmonary fibrosis. The Formative Assessment platform profiles individual learning needs related to the management of IPF and recommends personalized education to meet each learner’s unique needs. This activity consists of three modules, each taking approximately 15 ...
ACHL

Treating Tardive Dyskinesia: Clinical Challenges and Patient Perspectives

This Clinical Commentary consists of an HD video roundtable discussion with two leading expert psychiatrists in the field, who participate in a panel discussion of tardive dyskinesia (TD) as a widespread and undertreated condition in psychiatric populations, as well as the importance of evidence-based differential diagnostics, newly approved therapeutics for treatment of the condition, and strategies for both personalized and improved patient care. This activity additionally includes an interv...
ACHL

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.